Following AstraZeneca's acknowledgment of a rare side effect associated with its COVID-19 vaccine, known as Covishield in India, the UK pharmaceutical giant extended sympathy to those impacted. Reaffirming its dedication to patient safety amidst concerns about potential rare side effects, AstraZeneca emphasised the vaccine's overall safety profile....
Lilavati trustee alleges Rs 500 crore scam by kin
Prashant Mehta, a trustee of Lilavati Hospital & Research Centre in Mumbai, accused former trustees of misappropriating ₹500 crore in trust funds. Allegations include payments for private disputes, bogus donations, and advances to real estate firms. Prashant named his late uncle Vijay Mehta, cousin Niket Mehta, and aunt Sushila Mehta in the accusations.
from...
Covishield Case: Bereaved parents to take Serum Institute of India to Court following AstraZeneca's rare side effect admission
The parents of a woman allegedly deceased after receiving the Covishield vaccine plan to file a case against the Serum Institute of India (SII). This decision follows AstraZeneca's acknowledgment in court that their Covid shot can cause a rare side effect, providing hope for the parents in seeking justice. AstraZeneca faces a class-action lawsuit over...
Covishield Side Effects: What's TTS syndrome, symptoms, and danger signs you shouldn't ignore
Covishield TTS: AstraZeneca has acknowledged the potential TTS side effects from its COVID-19 vaccine Covishield, used widely in India. TTS, Thrombosis with Thrombocytopenia Syndrome, is rare but serious, marked by blood clots and low platelet levels. Symptoms include headaches, blurred vision, and chest pain. Dr. Jayadevan emphasizes awareness, stressing...
Indian pharmaceutical industry set for major transformation: Dilip Shanghvi
At an annual meeting of the USA-India Chamber of Commerce in Boston, Shanghvi told a gathering of leading multinational drug makers about the "clear positive improvements" that are taking place in India. Sun Pharma itself has built a pipeline of over 10 specialty and innovative drugs in the US. It's done this through acquisitions of late-stage drugs...
Drug firms told to set up system for 'prompt' recalls
India enforced 'Schedule M' for drug manufacturers, emphasizing quality, recall systems. Companies must comply with strict rules on hygiene, audits, and reporting defects to DCGI for improved drug quality and safety measures. For seamless implementation of the new rules, the health ministry has been conducting workshops and giving presentations to...
AstraZeneca acknowledges covid vaccine can lead to rare side effect TSS in court; Here's what we know
AstraZeneca, in collaboration with the University of Oxford, admits its Covid-19 vaccine can cause a rare side effect, Thrombosis with Thrombocytopenia Syndrome (TTS). The admission comes amidst a lawsuit alleging severe harm and deaths caused by the vaccine. Kate, wife of a victim, demands an apology and fair compensation after a three-year struggle....
Manipal Hospitals to acquire Kolkata's Medica Synergie
Manipal Hospitals has acquired an 87% stake in Kolkata-based Medica Synergie, a subsidiary of Singapore's Temasek Holdings. The deal, valued at Rs1200 crore, is part of Manipal Hospitals' strategy to expand its presence in Eastern India. The acquisition comes after Sheares Health, the healthcare platform owned by Singapore's Temasek Holdings, acquired...
Glenmark Pharma gets USFDA nod for generic anti-inflammatory drug
Glenmark Pharmaceuticals received USFDA approval for generic Acetaminophen and Ibuprofen tablets. The product, a version of Advil Dual Action, will be distributed by Glenmark Therapeutics Inc, USA. Advil Dual Action achieved annual sales of around USD 84.1 million. Glenmark has 195 products authorized for distribution and 52 ANDAs pending approval.
from...
Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in India
Doctors say patients come with specific queries regarding weight-loss drugs, which have become both the first preference and the last resort for some. “I would rather go for these short cuts that the pharma industry offers than go under the knife for my appearance,” says Rajput. The drugs — Wegovy and Ozempic — which have the same ingredient, semaglutide,...
‘Obese people should opt for a structured programme of diet, exercise & medication’
"Nothing comes without a downside. These molecules do produce significant nausea and vomiting in some people — to the extent that they have to discontinue the medication. Some may develop diarrhoea, some may have severe constipation. Others may not like the way they lose weight—they may feel very shrunken or their face may seem very thinned out. That’s...
India becoming attractive for clinical trials, says pharma industry leaders
Over the past decade, India has seen significant improvements in its clinical trial landscape, with a 15-18% growth in phase two and three trials. This growth is attributed to 10 modifications to the Drugs and Cosmetics Act since 2013, aimed at simplifying the process. Despite these advancements, conducting trials in India can still be challenging....
Pharma, financial services lead in female KMP representation
While female KMPs in the financial services sector were all professional leaders, in pharma, they were promoters, according to data from FY23 collated for ET by executive search firm EMA Partners India.However, Indian companies continue to struggle to have a better gender balance when it comes to KMPs. According to the Companies Act, KMPs are the CEOs...
PE Advent International queues up for a stake in Apollo 24/7
Apollo 24/7 is part of Apollo HealthCo, a subsidiary of Apollo Hospitals. HealthCo also houses the pharmacy distribution business and a 25.5% interest in Apollo Pharmacy. It accounts for about 40% of Apollo Hospitals’ revenue.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Vy62hgj
via IFT...
Pharma leads in assigning key managerial roles to women
While female KMPs in the financial services sector were all professional leaders, in pharma, they were promoters, according to data from FY23 collated for ET by executive search firm EMA Partners India.However, Indian companies continue to struggle to have a better gender balance when it comes to KMPs. According to the Companies Act, KMPs are the CEOs...
Medical devices companies to soon have 'unique' pricing model
At present there is no separate pricing framework followed for medical devices. The government has been using the same framework which was created for drugs in case they want to regulate the price of any medical device. Earlier, it had regulated the prices of stents and knee implants under the Drug Price Control Order.
from Healthcare/Biotech-Industry-Economic...
Sugar, you shrunk the kids: Bouquet of diseases nestled within your child's nutritional drinks
Have you been a fan of "nutritional" drinks since childhood? Chances are, the milk you consumed was laden with about 50% sugar. This habit may have continued into adulthood, contributing to India's reputation as the "diabetes capital of the world." Recent controversies surrounding Nestle's Cerelac have exposed the issue of added sugar in products for...
Nestle, Dr Reddy's to form JV to market nutraceutical brands in India
Nestle India and Dr. Reddy’s form a joint venture to introduce new nutraceutical brands in India. The collaboration merges health solutions and commercial capabilities to enhance consumer access and affordability.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/p0rLGDf
via IFT...
Optimizing gut health: Avoid these foods for better digestive wellness
Protect your gut health by avoiding certain foods. Processed foods, artificial sweeteners, high-sugar items, fried foods, alcohol, and processed meats can harm gut bacteria and cause inflammation, leading to digestive issues. Opt for whole, nutrient-rich foods for better digestive wellness.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wrIT41c
via...
Govt expands committee for drug and medical device pricing reforms, includes more industry representation
The government has expanded a committee to include more industry representation for reviewing drug and medical device pricing reforms. This move aims to ensure better availability of medicines and devices, while also providing incentives for industry growth and export sustainability. The committee will engage with industry experts and associations...
Revamped health schemes to focus on kids' nutrition
"The idea is to come up with a comprehensive physical and mental development programme for schoolchildren, with a focus on nutrition to minimise cases of anaemia and to strengthen their mental health to reduce increasing incidence of anxiety, depression and suicides," said a senior government official.
from Healthcare/Biotech-Industry-Economic Times...
Dr Reddy's recalls six lots of drug in US due to subpotency
Dr Reddy's Laboratories on Tuesday said it is voluntarily recalling from the US market six lots of medication, indicated to reduce blood phenylalanine (Phe) levels, on account of being subpotent. The company is recalling affected lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level due to powder discolouration in...
Panel to finalise list of over-the-counter drugs for sale at general stores
A three-member committee of gynecologists has been formed to finalize a list of over-the-counter (OTC) drugs that will be available in regular stores without the need for a prescription. The committee, chaired by Directorate General of Health Services Atul Goel, aims to complete the list within two weeks. This move is part of India's new OTC policy...
Zydus Lifesciences launches generic drug for overactive bladder in US market
Zydus is among the first suppliers to launch the generic version of Mirabegron extended-release tablets (USP 25 mg) in the US market. The company is also preparing to launch the 50 mg tablets in the market. Mirabegron is indicated for the treatment of Overactive Bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency.
from...
USFDA pulls up Natco Pharma for manufacturing lapses at Telangana plant
Natco Pharma's Telangana plant violated cleanliness and sterilisation standards at Kothur Village facility per USFDA. The warning letter mentioned cross-contamination, inadequate cleaning procedures, and the need for comprehensive investigations and corrective actions.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/g7FPTMO
via IFT...
Healthcare needs tailored financing, knowledge and partnerships: World Bank President Ajay Banga
Healthcare needs tailored financing, knowledge and partnerships, says World Bank President Ajay Banga. He said, during and after COVID, financing for healthcare has increased but to make healthcare affordable and bring it to the reach of all, it needs knowledge and partnerships along with financing.
from Healthcare/Biotech-Industry-Economic Times...
Middle East crisis escalation may hurt pharma exports
While exports have not been affected so far, the next few days are crucial because, if there is serious escalation in the conflict, it could impact the whole Middle East and North Africa (MENA) region. Many Indian pharma companies have a significant presence in the region.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/aXf93DV
via...
CDCSO issues distribution guidelines for pharma products in market to curb substandard medicines
The Central Drugs Standard Control Organisation (CDSCO) has released draft guidelines on good distribution practices to prevent the introduction of spurious, adulterated, and sub-standard pharmaceutical products in the market. The guidelines are in line with the WHO Technical Report Series on good storage and distribution practices for such products.
from...
Govt mulls allowing sale of common medicines in general stores
India's committee, under Atul Goel's leadership, is pioneering the development of guidelines for over-the-counter medicines to improve accessibility. This initiative marks a significant step towards streamlining non-prescription drug regulations.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mnvWiqE
via IFT...
Complaint filed against Natco Pharma in US by Fresenius Kabi
Natco Pharma faces a legal complaint from Fresenius Kabi in the US District Court regarding the marketing of Diazepam injection prefilled syringe. Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GmbH filed the complaint against Natco Pharma USA LLC (formerly Dash Pharmaceuticals LLC).
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tzlXKS7
via...
HCG founder floats $20 million healthcare and life sciences fund
BS Ajaikumar launched the $20 million Inviga Healthcare Fund to support Indian early-stage healthcare companies, addressing funding and operational challenges. The fund recently invested $2 million in Mynvax for novel vaccines.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gEVcLkY
via IFT...
HC upholds its earlier order on asthma drug Indamet against Glenmark Pharma
Sun Pharma Laboratories, a wholly-owned subsidiary of Sun Pharmaceutical Industries, and Glenmark are contesting over their right to use drug names “Istamet” and “Indamet”, respectively, which Sun Pharma finds to be deceptively similar and confusing.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/E5wHpdq
via IFT...
Jubilant gets VAI classification from USFDA for Roorkee unit
As per the USFDA, a VAI inspection classification indicates that although investigators found and documented objectionable conditions during the inspection, FDA will not take or recommend regulatory or enforcement action because the objectionable conditions do not meet the threshold for action at this time.
from Healthcare/Biotech-Industry-Economic...
IIT Kanpur joins hands with Blockchain for Impact to accelerate healthcare innovation
IIT Kanpur partners with BFI under BFI-Biome Virtual Network Program to boost healthcare startups. $150,000 pledged for SIIC healthcare innovations. Emphasis on entrepreneurial initiatives, biomedical research, and impactful solutions.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fEBy68i
via IFT...
Calcutta HC passes interim order in Glocal case
UpHealth, a digital health company, acquired a 95% stake in Glocal in 2020. The dispute started after UpHealth claimed their right to two directors on the board of Glocal as per the share purchase agreement (SPA) in September 2022, which was defeated in an extraordinary general meeting (EGM).
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/6FdhQIa
via...
Do you consume protein supplements for health gains? Snapdeal's Kunal Bahl has a serious warning for you
A recent study exposes alarming findings about protein supplements, uncovering mislabeling, toxin contamination, and potential health risks. Led by researchers from Rajagiri Hospital in Kerala and a US-based tech entrepreneur, the study highlights the urgent need for stricter regulation in the supplement industry. Misleading labels and harmful toxins...
Max Healthcare Institute to invest Rs 5,000 cr on doubling bed capacity in 4-5 years
Max Healthcare Institute Ltd plans to invest Rs 2,500 crore in Uttar Pradesh (UP) which includes setting up of a new 500 beds hospital on 5.6-acre parcel of land located at Shaheed Path and augmentation of capacity of the acquired facility.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Xsq1Qx7
via IFT...
ChrysCap buys small stake in generics company La Renon for Rs 600 cr
Incorporated in 2007 by Pankaj Singh, La Renon is engaged in the manufacturing and marketing of branded generic formulations. ChrysCapital is close to acquiring a minority stake in La Renon Healthcare via secondary sale of shares, at a valuation of Rs 6,500 crore ($800 million), ET first reported on February 12.
from Healthcare/Biotech-Industry-Economic...
Royal Phillips to expand its Healthcare Innovation Centre in Pune
Royal Philips expands its Pune Healthcare Innovation Centre, integrating R&D teams for various businesses. The new facility promotes sustainability and innovation, aiming to enhance patient and staff experiences while reducing the cost of care.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mqN5Kpz
via IFT...
India rubbishes Lancet report, says spending on healthcare is at all-time high
A recent Lancet report highlighted India's healthcare spending low at 1.2% of GDP, but government sources defended increased investments. The Health Ministry aims to reach 2.5% by 2025, with budgets rising significantly. Flagship initiatives like Ayushman Bharat aim to improve healthcare access, while efforts focus on reducing out-of-pocket expenses...
Glenmark recalls 6,528 bottles of blood pressure drug in US
As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Mb9vjKz
via IFT...
Neuberg Diagnostics plans to raise $100 million to fund acquisitions
Neuberg, which runs a pan-India diagnostic chain, has appointed O3 Capital as the investment banker and is currently in talks with potential investors, Velu said in an interview. The Chennai-based company plans to use the fresh capital to expand its radiology business through acquisitions, chairman GSK Velu said.
from Healthcare/Biotech-Industry-Economic...
IPC issues alert on painkiller drug nimesulide over adverse reaction
Pharma standards body Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert over nimesulide, saying the pill can trigger rashes on the skin (fixed drug eruption). It asked consumers and healthcare professionals to closely monitor the use of the drug and report any adverse reaction to the National Coordination Centre-Pharmacovigilance...
USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant
The US Food and Drug Administration (USFDA) has issued a warning letter to Kilitch Healthcare India for manufacturing lapses at its plant in Maharashtra. The letter highlights various violations of current good manufacturing practice (CGMP) regulations, including packing drugs in insanitary conditions and failing to establish proper procedures to prevent...
Warburg buys majority stake in ophthalmic device company Appasamy
Warburg Pincus buys majority stake in Chennai's Appasamy Associates, a top Indian ophthalmic equipment and IOLs manufacturer. Appasamy CEO will continue to lead biz with support from promoter family
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/YJiZFs9
via IFT...
Dr Reddy's launches migraine management device in Europe
The launch marks the company's entry into digital therapeutics in Europe, the Hyderabad-based drug major said in a statement. Nerivio is approved by the US Food and Drug Administration (USFDA), and is CE-mark certified in Europe. Dr Reddy's launched Nerivio in India last year.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yiCAtSx
via...
'Demand for Indian healthcare profs to double nationally, globally by 2030'
Global shortage and an ageing population have spurred the demand for Indian healthcare professionals who are highly respected in the international markets for their skills, NLB Services CEO Sachin Alug told PTI.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/WnLvqjS
via IFT...
Warburg Pincus acquires Chennai's Appasamy Associates
PSN Appasamy's Appasamy Associates, a key player in Indian ophthalmic market, focuses on affordable equipment and cataract surgeries. Warburg Pincus's investment reinforces growth potential in the sector.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/icYQS0o
via IFT...
Relief for pharma companies as API prices see a sharp fall
India's pharmaceutical industry, which is dependent on China for APIs, intermediates and bulk drugs, had seen an exponential price increase during Covid times. The rise in API prices continued until early this year. However, things have started to change, people in the know told ET.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/aTGh6FC
via...
Natco Pharma gets warning letter from USFDA for Telangana plant
Natco Pharma, a pharmaceutical company, received a warning letter from the USFDA regarding its manufacturing plant in Telangana. This came after the FDA conducted an inspection of the company's facility in Kothur last October, issuing eight observations under Form 483.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LWQxeCP
via IFT...
Strides Pharma gets USFDA nod for antidepressant medication
As per IMS, Fluoxetine tablets have a market size of USD 23.9 million. This approval further strengthens the company's presence in the Fluoxetine portfolio, complementing the existing approval of Fluoxetine capsules, which has a market size of USD106 million, the Bengaluru based firm said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hHZIsnJ
via...
Indian pharma market posts robust 9.5% growth in March
India's pharmaceutical market saw a 9.5% growth in March, reaching '16,158 crore in sales. The Moving Annual Total reached '197,976 crore with a 6.5% growth rate, with cardiology and anti-infectives among the top performers.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7reSJpZ
via IFT...
Lupin gets USFDA nod to market generic medication
Lupin has gained approval from the USFDA to market generic Valbenazine Capsules, used to treat tardive dyskinesia. This medication is equivalent to Neurocrine Biosciences, Inc's Ingrezza Capsules. Lupin is among the first applicants for this generic drug, entitling them to 180 days of shared exclusivity.
from Healthcare/Biotech-Industry-Economic Times...
AstraZeneca, Daiichi Drug gets broad tumor approval in US
Enhertu, a collaboration between AstraZeneca and Daiichi Sankyo, gains FDA approval for treating HER2-positive solid tumors spread throughout the body, marking a breakthrough in cancer treatment. It's the first antibody drug conjugate with such wide clearance, offering new hope for patients with limited treatment options. AstraZeneca anticipates further...
Piramal Alternatives invests Rs 110 crore in Biodeal Pharmaceuticals
Piramal Alternatives invested Rs 110 crore in Noida-based Biodeal Pharmaceuticals through convertible instruments. The funding will enhance infrastructure, technology, and a nutraceuticals manufacturing facility. Biodeal is a key contract manufacturing player, specializing in nasal sprays and achieving PIC/S approval.
from Healthcare/Biotech-Industry-Economic...
Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot
Weight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in generic supply. The Bengaluru-based company secured UK approval for the first generic version of liraglutide injectible, positioning itself as a leader in this evolving market.
from Healthcare/Biotech-Industry-Economic...
World Health Day: India's healthcare sector reflects 12.59 per cent growth in 2024-25
The hospital market in India, valued at USD 98.98 billion in 2023, is set to continue its upward trajectory, with projections indicating a CAGR of 8.0 per cent from 2024 to 2032. By 2032, the market is estimated to reach value of USD 193.59 billion.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ElbLZT1
via IFT...
Sanofi looks for accelerated growth in India; plans fast-tracking of product pipeline
Sanofi, a leading French pharmaceutical company, aims to expand its presence in the Indian market by introducing new drugs, enhancing localization efforts, and collaborating with domestic firms. Managing Director Rodolfo Hrosz highlights the significant growth potential in India and emphasizes the company's focus on addressing the diabetes segment.
from...
India's Ayurveda product market to reach Rs 1.2 lakh crore by FY28: Study
India's Ayurveda market is poised to grow to USD 16.27 billion by FY28, driven by demand for natural remedies, government support, and the sector's potential to position itself in global markets, as highlighted at the CII AYUSH Conclave.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fr5DAdq
via IFT...
There can't be shortage of Polio vaccine; Serum Institute can make it: CEO Adar Poonawalla
Pune-based Serum Institute of India (SII) is prepared to increase production of injectable poliomyelitis vaccine (IPV) to fill the gap left by France's Sanofi closing its manufacturing plants in India. SII currently supplies half of the 20 million IPV doses to the government's immunization program and can provide additional doses with a 3-4 month notice....
Apollo Hospitals report finds Indians are getting cancer at lower ages than West
The study, which is the fourth edition of its flagship Health of Nation Report, highlighted the fastest rise in cancer cases and also the average age of incidence has also gotten significantly younger in India.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4nteOG9
via IFT...
Digital database of organ donors on cards for smooth transplants
The register will serve as a single platform with Aadhaar authenticated data for all donors and patients waiting for organ transplant to ensure in-time and transparent organ donation in the country while doing away with the middlemen. India has 0.14 million potential donors who have voluntarily pledged their organs and the government aims to have 10...
Lupin appoints Dr Ranjana Pathak as chief quality officer
Dr. Ranjana Pathak appointed Lupin's chief quality officer, succeeding Johnny Mikell. With 30 years of experience, she led quality at Cipla, Watson/Actavis, and Endo Pharmaceuticals. Lupin invests in R&D.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/40PQcrC
via IFT...
Aster DM completes separation of Gulf business, plans to add 1,700 beds in India in next 3 years
Aster DM Healthcare has finalized the separation of its India and Gulf (GCC) businesses. A consortium led by Fajr Capital acquired a 65% stake in Aster GCC, while the Moopen family retained 35%. In India, the family holds a 41.88% stake. The separation aims to enhance strategic and financial flexibility.
from Healthcare/Biotech-Industry-Economic Times...
General Atlantic buys hospital chain Ujala Cygnus
General Atlantic acquires Ujala Cygnus for Rs1600 crore, with existing investors exiting fully. Ujala Cygnus to enhance infrastructure and care quality. Probal Ghosal and Shantanu Rastogi commend the company's achievements.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VMxwpkY
via IFT...
Bharat Biotech, Bilthoven Biologicals collaborate for oral polio vaccines production, supply
Bharat Biotech on Tuesday said it has collaborated with the Netherlands-based Bilthoven Biologicals B.V, a wholly-owned arm of Serum Institute of India, to strengthen production and supply security of oral polio vaccines. An agreement has been signed between the two partners under which Bharat Biotech will procure drug substances for the production...
India all set to make Penicillin G after three decades on PLI push
India stopped producing the two input drugs about three decades ago and since then it has relied on China for their supplies. "As of now, we are largely dependent on China. With the initiative of the production-linked-incentive scheme, companies like Aurobindo are coming up with fermentation-based products like PenG," said Ravi Uday Bhaskar, director...
Mubadala plans big deals in India's healthcare space
Abu Dhabi's Mubadala Investment Company plans to expand in India's healthcare sector, seeking deals in the $200-500 million range. With a focus on pharmaceuticals, outsourced pharma services, and medtech, Mubadala aims to deploy capital meaningfully in India. This move aligns with Mubadala's strategy to generate sustainable financial returns. They...